An act relating to maintaining patient access to animal-derived thyroid medications

This bill requires Vermont's Office of Professional Regulation (OPR) and Department of Financial Regulation to find ways to keep animal-derived thyroid medications - like desiccated thyroid extract - available to patients who need them. It directs these agencies to implement feasible solutions without new laws and consult with healthcare providers, insurers, and patients with thyroid conditions. The OPR must report by January 2027 with findings, implemented options, and any needed legislative changes. The bill specifically aims to maintain access for patients for whom these medications are more effective or better tolerated than synthetic alternatives. It does not create new coverage requirements but mandates agency action to preserve current access pathways.